Table 3.
Overall (n = 1381) | HSI < 30 (n = 197) | 30 ≤ HSI < 36 (n = 393) |
36 ≤ HSI < 42 (n = 432) |
HSI ≥ 42 (n = 359) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Paraxanthine | 1-MUA | Paraxanthine | 1-MUA | Paraxanthine | 1-MUA | Paraxanthine | 1-MUA | Paraxanthine | 1-MUA | |
β (p-Value) |
β (p-Value) |
β (p-Value) |
β (p-Value) |
β (p-Value) |
β (p-Value) |
β (p-Value) |
β (p-Value) |
β (p-Value) |
β (p-Value) |
|
Phosphorus, mmol/L | ||||||||||
Quartile 1 (0.55–1.10) |
Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Quartile 2 (1.13–1.20) |
−0.01 (0.94) | −0.02 (0.69) | 0.07 (0.80) | −0.09 (0.65) | 0.01 (0.96) | −0.02 (0.90) | −0.19 (0.26) | −0.15 (0.25) | 0.13 (0.58) | 0.11 (0.47) |
Quartile 3 (1.22–1.36) |
−0.04 (0.58) | 0.03 (0.61) | −0.19 (0.51) | 0.07 (0.69) | 0.04 (0.75) | −0.01 (0.94) | −0.03 (0.87) | 0.08 (0.46) | −0.11 (0.48) | 0.07 (0.54) |
Quartile 4 (1.38–2.62) |
0.13 (0.15) | 0.11 (0.22) | 0.05 (0.90) | 0.01 (0.96) | 0.29 (0.10) | 0.25 (0.04) | 0.05 (0.82) | 0.11 (0.51) | 0.14 (0.43) | 0.03 (0.87) |
Bicarbonate, mmol/L | ||||||||||
Quartile 1 (15–24) |
Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Quartile 2 (25–25) |
0.15 (0.21) | 0.01 (0.88) | 0.29 (0.24) | 0.06 (0.72) | 0.03 (0.92) | −0.05 (0.74) | 0.24 (0.20) | 0.20 (0.14) | 0.13 (0.58) | −0.12 (0.43) |
Quartile 3 (26–26) |
0.12 (0.24) | 0.12 (0.10) | 0.33 (0.25) | 0.12 (0.65) | 0.16 (0.31) | 0.15 (0.20) | −0.01 (0.96) | 0.08 (0.59) | 0.19 (0.36) | 0.17 (0.24) |
Quartile 4 (27–38) |
0.16 (0.06) | 0.13 (0.12) | 0.47 (0.19) | 0.12 (0.67) | 0.19 (0.28) | 0.23 (0.19) | 0.04 (0.82) | 0.14 (0.33) | 0.37 (0.09) | 0.15 (0.34) |
eGFR | ||||||||||
>90 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
60 to 90 | −0.23 (0.0031) | −0.11 (0.08) | −0.64 (0.06) | −0.52 (0.03) | −0.36 (0.10) | −0.16 (0.24) | −0.34 (0.04) | −0.19 (0.28) | 0.14 (0.32) | 0.04 (0.78) |
<60 | −0.39 (0.0010) | 0.25 (0.02) | −1.38 (0.04) | −0.62 (0.21) | −0.61 (0.03) | 0.15 (0.49) | −0.79 (0.0018) | 0.27 (0.14) | 0.68 (0.11) | 0.52 (0.23) |
* Caffeine metabolites indices were the ratios of caffeine metabolites to caffeine intake, including creatine adjusted paraxanthine/caffeine intake and creatinine adjusted 1-methyluric acid/caffeine intake; indices were log transformed. List of abbreviations: 1-MUA: 1-methyluric acid. Bolded p for trend values indicate significance using a significance level of 0.05.